跳至主要内容
临床试验/EUCTR2015-002948-14-HU
EUCTR2015-002948-14-HU进行中(未招募)1 期

Application of a new radioligand F-18 FET, and its clinical benefit in the diagnosis of primary and secondary brain tumors -

PET Diagnosztikai Kft.0 个研究点目标入组 43 人开始时间: 2015年9月24日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
43

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • histologically confirmed primary or secondary brain tumor
  • previous MRI study (T1WI, PDWI, T2WI, postcontrast T1WI)
  • clinical history is available
  • cooperating patient
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 60

排除标准

  • non-cooperating patient
  • clinical data are not available
  • claustrophobia
  • patient refused participation
  • pregnancy or breast feeding

研究者

发起方
PET Diagnosztikai Kft.

相似试验